Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2019 third-quarter earnings
Johnson & Johnson Q3 2019 Earnings

What you need to know about Johnson & Johnson’s 2019 third-quarter earnings

Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.

Share Article
share to
Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its third-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 135,000 employees across the globe working every day to help change the trajectory of health for humanity.

“We delivered strong revenue and earnings growth during the third quarter, while also making strategic investments that advance our innovative pipeline across all three business segments,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “Our colleagues around the world are passionate and committed to driving robust performance, while providing healthcare solutions that deliver long-term value to our patients, consumers, employees, communities and shareholders.”

For more details about the company’s 2019 third-quarter results, and to read a comment from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.

UPDATED Johnson & Johnson Q3 2019 Earnings infographic

Johnson & Johnson’s 2019 3rd-Quarter Earnings

Read the earnings press release, which includes full financial details for the third quarter of the year.

Want to see more company earnings information? Find several years of Johnson & Johnson’s quarterly and full-year results here.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.